Infectious Diseases News

Spread the word about the latest research, updates, products, services and treatment advances regarding infectious diseases. This section covers information about diseases caused by bacteria, viruses, fungi or parasites, of interest to clinicians, scientists, patients and medical and pharmaceutical industry professionals.

Parvus Announces Collaboration with AbbVie to Develop IBD Therapies Based on the Parvus Navacim Platform Technology

The collaboration will combine AbbVie’s expertise in Immunology with Parvus’ innovative Navacim™ regulatory T cells (Treg) immune tolerization platform technology to develop therapies for Inflammatory Bowel Disease Parvus Therapeutics announced today that it has entered into an... - March 20, 2024 - Parvus Therapeutics U.S., Inc.

IVIEW Announces Presentation of Positive Topline Results in Phase II Clinical Study of IVIEW-1201 for the Treatment of Bacterial Conjunctivitis at ARVO 2024

IVIEW Announces Presentation of Positive Topline Results in Phase II Clinical Study of IVIEW-1201 for the Treatment of Bacterial Conjunctivitis at ARVO 2024

IVIEW Therapeutics Inc. announces to present the positive topline result in the Phase II Clinical Study of IVIEW-1201 for the Treatment of Bacterial Conjunctivitis in the upcoming 2024 ARVO (The Association for Research in Vision and Ophthalmology) national meeting in Seattle, WA. The Presentation... - February 28, 2024 - iView Therapeutics Inc.

Gotham Biotech’s Histoplasma Urinary Antigen EIA Kit Now Available for Purchase as Histoplasma Spreads in the U.S.

Gotham Biotech’s Histoplasma Urinary Antigen EIA Kit Now Available for Purchase as Histoplasma Spreads in the U.S.

Histoplasmosis is a systemic disease caused by the thermally dimorphic fungus Histoplasma capsulatum. H. capsulatum is distributed worldwide and endemic to the Ohio and Mississippi River Valleys, where the CDC estimates 60% to 90% of people who live in the region have been exposed to the fungus at some point during their life, and to certain regions of Central and South America. Medicare records from 2007 to 2016 have found cases of histoplasmosis have now spread to 47 states and Washington, DC. - February 15, 2024 - Gotham Biotech

QuBind.com Makes Major Strides in T-Cell Immunotherapy with Revolutionary AI Innovation

In just 18 months, the young startup QuBind.com has achieved a remarkable breakthrough in T-cell immunotherapy, developing an advanced AI stack that is set to revolutionize personalized medicine. This significant milestone, reached with predominantly bootstrap funding, support from friends, family, and a strategic investment from a handful general partners in the PE sector, underscores the company's innovative spirit and scientific prowess. - December 05, 2023 - QuBind Technologies Corp

GeneProof Announces Expansion of Its IVDR-Certified PCR Portfolio

GeneProof, a leader in molecular diagnostics, today announced the addition of six new IVDR-certified PCR kits to its expansive portfolio. This comes as a testament to the company’s dedication to delivering its entire portfolio of approximately 80 products as IVDR compliant by 2027. Currently,... - October 03, 2023 - ALPCO

Gotham Biotech's New Histoplasma Urinary Antigen EIA Kit Now Available for Purchase

Gotham Biotech's New Histoplasma Urinary Antigen EIA Kit Now Available for Purchase

The Gotham Biotech Histoplasma Urinary Antigen EIA is an enzyme immunoassay (EIA) intended to qualitatively detect the presence of Histoplasma capsulatum galactomannan antigen in human urine specimens. This kit, when used in conjunction with other diagnostic measures, can be used as an aid in the diagnosis of histoplasmosis. - September 08, 2023 - Gotham Biotech

Lucielle Urgent Care Expands Telemedicine Services to Reach More Patients

Lucielle Urgent Care Expands Telemedicine Services to Reach More Patients

Lucielle Urgent Care, a Maryland corporation, has decided to expand telemedicine services in order to reach more patients in Towson, Maryland. - August 02, 2023 - Lucielle Urgent Care

Emmanuel J. Ajala Chosen as a Lifetime Featured Member by Strathmore’s Who’s Who Worldwide

Emmanuel J. Ajala of Bronx, New York, has been chosen as a Lifetime Featured Member by Strathmore’s Who’s Who Worldwide Edition for his outstanding contributions and achievements in the field of research. About Emmanuel J. Ajala Emmanuel J. Ajala is a biomedical researcher/principal... - July 26, 2023 - Strathmore Worldwide

Code Tenderloin New Partnership/Internship with Renegade.Bio and Tougaloo College

Code Tenderloin New Partnership/Internship with Renegade.Bio and Tougaloo College

Code Tenderloin is a non-profit that provides dignity and opportunity through intense job readiness and workforce development program serving those in need. Through barrier removal, we can serve those in life transitions with jobs, education, training, and connections to our referral network of housing, health, reentry programs, and child care services. - April 18, 2023 - Code Tenderloin

Thermo Fisher Partners with ALPCO-GeneProof to Broaden Their CE-IVD Molecular Assay Portfolio

ALPCO-GeneProof, a global leader in diagnostics, and Thermo Fisher announced a strategic partnership that brings the TaqPath Menu | GeneProof PCR kits to market. The partnership combines the strengths of ALPCO-GeneProof’s expertise in molecular diagnostics with Thermo Fisher’s robust... - April 17, 2023 - ALPCO

Emmanuel J. Ajala Honored as a Professional of the Year for 2023 by Strathmore’s Who’s Who Worldwide

Emmanuel J. Ajala, of Bronx, New York, has been recognized as a Professional of the Year for 2023 by Strathmore’s Who’s Who Worldwide Edition for his outstanding contributions and achievements in the field of research. About Emmanuel J. Ajala Emmanuel J. Ajala is a biomedical... - March 29, 2023 - Strathmore Worldwide

Santa Fe BioLabs Develops Optimized and Selective Media for the Pathogenic Yeast Candida auris and is Awarded Wide-Ranging Patent for Design of Selective Microbial Media

Santa Fe BioLabs Develops Optimized and Selective Media for the Pathogenic Yeast Candida auris and is Awarded Wide-Ranging Patent for Design of Selective Microbial Media

Santa Fe BioLabs concluded development of ReCand, a medium for optimized colony formation of dry Candida auris, and AuriFind, a medium for identification by selective growth of viable Candida auris. A patent has been granted for media development based on the underlying principle of modulation of toxicity by quaternary ammonium compounds. - February 16, 2023 - Santa Fe BioLabs LLC

PH Hession Enterprise Says China’s Slowing Growth Could Impact Global Economy

Report by PH Hession Enterprises shows China’s growth could be hindered in the coming months following the termination of its Zero COVID Policy. - January 10, 2023 - PH Hession Enterprise

MAKO Medical Expands Popular ASPT-Accredited Phlebotomy Program

MAKO Medical Expands Popular ASPT-Accredited Phlebotomy Program

Mako Medical and Mako Medical Laboratories expands accredited phlebotomy school to develop and train new students. - December 31, 2022 - Mako Medical Laboratories

The Alliance, Powered by Mako Medical, Expands Into New Jersey

The Alliance, Powered by Mako Medical, Expands Into New Jersey

Mako Medical expands its presence into New Jersey. The Alliance is a national network of laboratories that are coming together to form one lf the largest labs in America. - December 30, 2022 - Mako Medical Laboratories

Mako Medical Donates $25,000 to Help Families for Christmas

Mako Medical Donates $25,000 to Help Families for Christmas

Mako Medical and CEO Chad Price team up with Erica Delong at G105 Radio to help families in need for Christmas. - December 30, 2022 - Mako Medical Laboratories

Dr. Frank Hamo’s Latest Book, “Post COVID-19 Long Hauler Risk of Diabetes Type One or Two Diagnosis, Management,” is a Guide to the Long-Term Consequences of COVID-19

Dr. Frank Hamo’s Latest Book, “Post COVID-19 Long Hauler Risk of Diabetes Type One or Two Diagnosis, Management,” is a Guide to the Long-Term Consequences of COVID-19

Fulton Books author Dr. Frank Hamo PhD, Biomedical Engineering, who has spent his entire biomedical engineering career bridging the gap of medicine and engineering to deliver advanced healthcare monitoring options, has completed his most recent book, “Post COVID-19 Long Hauler Risk of... - December 30, 2022 - Fulton Books

Author Jason Boyce's New Audiobook, "Chronic Fatigue Gone!" is an Engaging Guide to Help Those That Have Exhausted Western Medicine in Their Path to Complete Healing

Recent audiobook release “Chronic Fatigue Gone! A Recovery Plan for Covid Long Haul, ME-CFS, Lyme,” from Audiobook Network author Jason Boyce, is a thorough examination of alternative wellness options for those who suffer from long COVID and chronic fatigue syndrome. After trying out multiple forms of treatment, Boyce shares his results to help listeners discover what might work best for them. - December 16, 2022 - Audiobook Network

HM Wilkins Imperial - China’s COVID Policy Causes Uncertainty

HM Wilkins Imperial report shows that China's zero-COVID policy threatens to harm China's economy and cause uncertainty at a crucial time. - December 03, 2022 - HM Wilkins Imperial

Immunodominant Announces Call for Initial Investment Round as Company Prepares for Phase 2 Study of Oral OTC COVID-19 Drug

Immunodominant Inc., a drug discovery and development company engaged in progressing innovative research from academia to commercialization, today announced its intention to begin an initial financing round of up to $30 million. Immunodominant also announced today that it is scheduling a Phase 2 clinical study after a pre-IND meeting with the FDA for LACTOVID, a novel, oral, over-the-counter drug for the prevention and treatment of COVID-19. - November 20, 2022 - Immunodominant

Long COVID Care Center Have Recently Published a Medical Report on the Symptoms of Long COVID Brain Fog

Long COVID Care Center Have Recently Published a Medical Report on the Symptoms of Long COVID Brain Fog

During rehabilitation after being infected with COVID-19, many patients said they experienced "brain fog." According to figures given in the study report, about 10% of patients infected with COVID-19 will experience long COVID. At present, it has become customary in the medical community to classify the symptoms of brain and nerve caused by COVID-19 infection as long-term COVID brain fog. - October 26, 2022 - Long COVID Care Center

Mirror Biologics, Inc. Announces Additional $20 Million Investment to Close Out $30 Million Series A Investment Round

Mirror Biologics, Inc. Announces Additional $20 Million Investment to Close Out $30 Million Series A Investment Round

Mirror Biologics, Inc., a clinical stage biopharmaceutical company today announced the completion of the final $20 million tranche of its $30 million Series A investment round with Bradbury Asset Management (Hong Kong), Limited. Bradbury provided an initial $10 million tranche for this round in... - October 11, 2022 - Mirror Biologics, Inc.

"The Quiet Epidemic" Documentary Officially Selected to Screen at the Prestigious Woodstock Film Festival

"The Quiet Epidemic" Documentary Officially Selected to Screen at the Prestigious Woodstock Film Festival

The Quiet Epidemic, the provocative new documentary about Chronic Lyme and tick-borne disease, will screen at the Woodstock Film Festival on September 30 and October 1. - September 15, 2022 - The Quiet Epidemic

Immunize Wisconsin Set to Launch

Immunize Wisconsin Set to Launch

A new statewide immunization coalition, Immunize Wisconsin, will provide fact-based resources, education, and grants. - September 06, 2022 - Wisconsin Chapter of the American Academy of Pediatrics

Edward Jones to Sponsor the Inaugural Hope for Kids Classic Benefiting the American Foundation for Children with AIDS

Edward Jones to Sponsor the Inaugural Hope for Kids Classic Benefiting the American Foundation for Children with AIDS

The Hope for Kids Classic looks to raise $20,000 with a matching grant for children with AIDS, and attract golfers in the Lebanon, PA area. - September 01, 2022 - American Foundation for Children with AIDS

SAP Smart Air Purifiers Teams Up with NBDair to Attend IFA 2022 with All-In-One Smart Air Quality Systems Aimed at Minimizing Infection/COVID-19 While Saving Energy

SAP Smart Air Purifiers Teams Up with NBDair to Attend IFA 2022 with All-In-One Smart Air Quality Systems Aimed at Minimizing Infection/COVID-19 While Saving Energy

The system provides a means by which to closely monitor air quality through one simple-to-control-and-manage dashboard, to provide good air quality in classrooms and meeting spaces while saving energy substantially and minimizing infection risks (including COVID). - August 30, 2022 - SAS Smart Air Systems

Peptineo, LLC Selected by EPA to Provide EPA Nationwide Coverage for Point of Care (POC) COVID-19 Testing

The Environmental Protection Agency (EPA), Cincinnati Acquisition Division (CAD), has awarded Peptineo LLC, an emerging aerospace, health services, and defense solutions company, a three-year Blanket Purchase Agreement (BPA) to support a comprehensive COVID-19 testing program in support of the... - August 07, 2022 - Peptineo

Meridian Diagnostics Helps Healthcare Practices Make Better Decisions

Meridian Diagnostics Helps Healthcare Practices Make Better Decisions

Meridian Diagnostics is a clinical diagnostic reference laboratory based in Colorado and offers services to clinics, laboratories, employers and healthcare practices nationwide. Their aim is to assist healthcare providers with making informed decisions for their patients. Meridian realizes you have many options for laboratory services, but their 18-24 hour turn-around-time on all results from UTI, toxicology, blood, and various respiratory pathogens makes them the lab of choice for providers. - July 26, 2022 - Meridian Diagnostics

Mako Medical CEO Chad Price Announces Company Expansion in Virginia with the Alliance

Mako Medical CEO Chad Price Announces Company Expansion in Virginia with the Alliance

Chad Price, CEO of Raleigh-based Mako Medical and Mako Medical Laboratories, announced the company is expanding its service throughout the state of Virginia by adding a new member to the laboratory Alliance. - July 18, 2022 - Mako Medical Laboratories

Chad Price, CEO of Raleigh-Based Mako Medical & Mako Medical Laboratories Launches a New Monkeypox Test

Chad Price, CEO of Raleigh-Based Mako Medical & Mako Medical Laboratories Launches a New Monkeypox Test

Chad Price, CEO of Mako Medical, recently announced his team has developed a monkeypox test. - July 18, 2022 - Mako Medical Laboratories

STI Testing Now Available at 15toKnow Locations

STI testing for syphilis and HIV-1/2 are available at Exton and Plymouth Meeting locations. - July 14, 2022 - 15toknow

Lice Charmers Head Lice Removal Service Expands in Oregon and Washington

Lice Charmers Lice Removal Portland (https://licecharmers.com) has increased its lice removal area to service more Oregon and Washington homes and families in need of in-home lice treatment. The company has successfully treated thousands of clients and decided it was time to expand to the Oregon... - July 01, 2022 - Lice Charmers

AIDS Walk South Dallas 2022

AIDS Walk South Dallas 2022

11th Anniversary of AIDS Walk South Dallas - 5K Walk - Saturday, June 25, 2022 at 8AM - June 11, 2022 - AIDS Walk South Dallas

National Mobile Wound Care Clinic Selects Dr. Thomas Serena as Medical Director

National Mobile Wound Care Clinic Selects Dr. Thomas Serena as Medical Director

Mendota Health is addressing the tremendous need for wound care in this country through a national mobile clinic and providing advanced treatments in the patient’s home setting. Dr. Thomas Serena has been selected as the new Medical Director of Mendota Health. - June 10, 2022 - Mendota Health

Ten to Life, Wild COVID Delirium Tales

Ten to Life, Wild COVID Delirium Tales

Joyner Outdoor Media Proudly Announces the Publication of "Ten to Life, Delirium Tales of a COVID-19 Survivor," by McGraw resident Mike Joyner - June 09, 2022 - Joyner Outdoor Media

Paradigm Immunotherapeutics to Present at LABEST 2022 Incubator Showcase

Paradigm Immunotherapeutics to Present at LABEST 2022 Incubator Showcase

Dr. Neil Bodie, CEO of Paradigm, will discuss Paradigm’s groundbreaking biological, virtual mask in his presentation, “A Breakthrough in SARS CoV-2/COVID Prophylactics.” Dr. Neil Bodie, CEO of Paradigm Immunotherapeutics (“Paradigm”), will present at the Los Angeles... - May 25, 2022 - Paradigm Immunotherapeutics

The Paliwoda Group Reflects on Next Big Investment Themes in a Post-Pandemic World

The Paliwoda Group Reflects on Next Big Investment Themes in a Post-Pandemic World

The Paliwoda Group Announces a New Series of Talks in Its NEXT BIG THING Campaign to Look at Innovation Spurred by COVID Responses. - May 24, 2022 - Paliwoda Group

Code3 Wins Gold at 2022 Stevie Awards for Best Use of Social - COVID-19 Response

Code3 Wins Gold at 2022 Stevie Awards for Best Use of Social - COVID-19 Response

Direct Relief, in Partnership with Facebook and Code3, Boost Vaccine Acceptance in the US Through Short and Smart Creative Campaigns - April 29, 2022 - Code3

Lumalier’s Germicidal UVC Solutions Help to Create Safer Spaces Amid COVID-19 and Improved Indoor Air Quality for Travelers and Airport Workers

Lumalier, an Evergreen UV brand, is pleased to announce that the company’s germicidal UVC (GUVC) products are now installed and operational in Reagan National Airport and Dulles International Airport, which are operated by the Metropolitan Washington Airports Authority. Airports have their own unique challenges for mitigating the spread of viruses and bacteria due to the high concentration of people and the broad range of geographic locations served. - April 28, 2022 - Lumalier

AvantGen Awarded Contract from NIH to Expedite the Commercialization of Its AccuRate COVID-19 SelfCheck OTC Test

AvantGen, a San Diego-based biotechnology company with a superior yeast display technology for facile antibody discovery and optimization, has entered the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) Tech program to expedite the commercialization of its... - March 09, 2022 - AvantGen

February Marks the Official Launch of National Self-Check Month; an Invaluable Reminder That Touching Yourself Could Help Save Your Life
Seychelles Medical Enables the Seychelles Islands to Revive Tourism

Seychelles Medical Enables the Seychelles Islands to Revive Tourism

Seychelles Medical is the only 24/7 COVID-19 testing laboratory in the Seychelles Islands. In the first 10 months since the islands reopened to visitors, Seychelles Medicals team of over 70 doctors and nurses carried out PCR Tests to over 100,000 visitors to Seychelles and issuing their fit to fly certificates to make their flights home. - February 03, 2022 - Seychelles Medical

Attorney General Sean D. Reyes Issues Statement on Supreme Court Vaccine Mandate Ruling

U.S. Supreme Court Rules in Vaccine Mandate Cases - January 14, 2022 - Utah Attorney General Sean Reyes

Viron Announces New CFO Hire

Viron Announces New CFO Hire

Viron Therapeutics Holdings, Inc., a Boston biotech company, is pleased to announce the appointment of Jodie Fisher as its Executive Vice President and Chief Financial Officer (CFO). Fisher will lead the Company’s finance organization and drive investor relations. Fisher’s entry into... - December 29, 2021 - Viron Therapeutics Holdings, Inc.

Dr. Stephen Petteruti of Intellectual Medicine Donates 100% of "No Show" Fees from 2021 to Adoption RI for Christmas Gifts

Dr. Stephen Petteruti of Intellectual Medicine donates $3,000 to Adoption RI to raise awareness this holiday season. - December 16, 2021 - Intellectual Medicine

The American Foundation for Children with AIDS Partners with The Giving Block to Accept Cryptocurrency on #CryptoGivingTuesday and Beyond

The American Foundation for Children with AIDS Partners with The Giving Block to Accept Cryptocurrency on #CryptoGivingTuesday and Beyond

The American Foundation for Children with AIDS looks to increase donations and attract younger, and tax savvy Cryptocurrency users to fight the battle against AIDS and extreme poverty in Sub-Saharan Africa. - November 30, 2021 - American Foundation for Children with AIDS

Mirror Biologics Announces Issuance of US Patent Covering Next Generation Therapeutic Vaccine Technology for Treatment of Cancer and Infectious Disease

Mirror Biologics Announces Issuance of US Patent Covering Next Generation Therapeutic Vaccine Technology for Treatment of Cancer and Infectious Disease

Mirror Biologics, Inc., a private clinical stage biopharmaceutical company, today announces the issuance of US Patent No. 11,160,852, “Method of Vaccinating Using Allogeneic Cells,” covering methods for creating a next generation of therapeutic vaccines against cancers and infectious... - November 17, 2021 - Mirror Biologics, Inc.

Innovation Saves Lives Amid Darkest Moments of COVID-19 Pandemic

"Effective communication is paramount and it works best when combined with trust. When there is a pandemic or another crisis that affects the human race, we should use our capabilities to the best of our ability and find solutions - together." - Dr. Ankit Bharat, Chief of Thoracic... - November 16, 2021 - Seraph Books

UserWise Facilitates FDA Emergency Use Authorization for Detect™ Over-the-Counter COVID-19 Test

UserWise Facilitates FDA Emergency Use Authorization for Detect™ Over-the-Counter COVID-19 Test

UserWise, Inc., a San Jose, California-based Human Factors consultancy for medical products, conducted an expedited 100-participant FDA-compliant human factors study within a 3-week span to facilitate an Emergency Use Authorization (EUA) for the Detect™ COVID-19 Test for over-the-counter home use. - November 08, 2021 - UserWise, LLC

Eyecheck Announces FDA IND Clearance of STRI Formula, the First-Ever Food-Based, Combination Product in the STRI Phase 2 Clinical Trial for COVID-19 Symptoms

Eyecheck intends to initiate the Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial to evaluate STRI Formula in non-hospitalized adults with COVID-19. This trial is expected to begin in November 2021. - November 04, 2021 - Eyecheck, Inc.

Press Releases 1 - 50 of 766